Psychometric assessment of a driving simulation task performed using an immersive virtual reality in cardiovascular rehabilitation: A randomized controlled trial - Scorecard - MDSpire

Psychometric assessment of a driving simulation task performed using an immersive virtual reality in cardiovascular rehabilitation: A randomized controlled trial

  • By

  • Roberto De Giorgi

  • Rossana Cuscito

  • Alessandra Piccionetti

  • Federico Gentili

  • Silvia Casolani

  • Cristiano Rubeca

  • Claudia Salera

  • Marco Iosa

  • Daniela De Bartolo

  • Simone Barbato

  • Giovanni Morone

  • Gaetano Tieri

  • June 15, 2026

  • 0 min

Share

Clinical Scorecard: Evaluation of a Driving Simulation Task in Immersive Virtual Reality for Cardiovascular Rehabilitation: Results from a Randomized Controlled Trial

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with cardiovascular disease
Care Setting

Key Highlights

  • Current evidence does not clearly demonstrate VR's superiority over conventional rehabilitation
  • Cybersickness may affect some users, particularly those with vestibular sensitivities

Guideline-Based Recommendations

Diagnosis

    Management

    • Multidisciplinary approach involving cardiologists, physiotherapists, and psychologists is suggested

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Further evidence is needed to confirm psychological and physiological outcomes in rehabilitation

        Clinical Best Practices

        • Ensure informed consent is obtained from all participants
        • Assess cognitive function prior to VR use to exclude patients with impairments

        Related Resources & Content

        Original Source(s)

        Psychometric assessment of a driving simulation task performed using an immersive virtual reality in cardiovascular rehabilitation: A randomized controlled trial

        • by Roberto De Giorgi, Rossana Cuscito, Alessandra Piccionetti, Federico Gentili, Silvia Casolani, Cristiano Rubeca, Claudia Salera, Marco Iosa, Daniela De Bartolo, Simone Barbato, Giovanni Morone, Gaetano Tieri

        • June 15, 2026

        Related Content

        Ischemia-modified albumin in children with clinically suspected acute myocarditis: diagnostic performance and incremental value beyond conventional biomarkers

        2026 Lipid Guidelines Beyond Statins:  Non- Statin Agents to Manage Dyslipidemias

        Dr. Talreja  discusses the 2026 standard of care for treatment of dyslipidemia with new screening guidelines and advanced therapy options.

        • June 12, 2026

        • 1 min
        Correction: Association between adjusted body size index and abdominal aortic calcification among US older adults aged 40 years and above from a cross-sectional survey of the NHANES 2013–2014